Clinical Trials
Evecxia Therapeutics and Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treatment
A drug development partnership between Evecxia Therapeutics and Quotient Sciences has resulted in the successful delivery of a Phase 1 clinical testing program for Evecxia’s drug candidate EVX-101, which is in development for major depressive disorder (MDD).
Quotient Sciences’ Translational...
News
Career Advancement Opportunities for Clinical Pharmacists
Clinical pharmacists play a vital role in the healthcare system, ensuring the safe and effective use of medications for patients. Their responsibilities go beyond dispensing drugs. They collaborate with healthcare teams, provide medication therapy management, and educate patients on...
BioPharma
Cell And Gene Therapy Market Soars, Forecasted At $82.24B
The global cell and gene therapy market has witnessed remarkable growth, with a market size of USD 15.46 billion in 2022. Projections indicate that by 2032, it could reach approximately USD 82.24 billion, showcasing a robust compound annual growth...
Drug Research
Growing Demand Reshaping The Future of Aseptic Fill Finish
It's important to highlight that aseptic fill finish operations demand skilled personnel, specialized automated equipment, a controlled cleanroom environment, and constant supervision to maintain the sterility and safety of the final pharmaceutical product.
Nevertheless, due to the high costs associated...
IT & Data Management
Automation Technology Reshaping The Prefilled Syringe Sector
Over the last two decades, technology has greatly expanded our capabilities and, consequently, raised expectations for manufacturers. These evolving capabilities have often aligned with, or perhaps even influenced, significant growth in certain pharmaceutical segments. One such niche is prefilled...
BioPharma
Biotech Innovations In The Face of Economic Uncertainty
While the pharmaceutical industry has traditionally been seen as recession-proof, with a constant demand for medicines and new treatment options, it currently faces significant challenges. Economic uncertainty is on the rise, increasing the risks associated with early drug discovery,...
News
Pistoia Alliance Launches Lab of the Future Report, Finding AI is Set to be Top Technology Investment for Life Sciences Companies Over Next Two...
The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, is releasing the results of a new global survey conducted in partnership with Open Pharma Research, organizers of the Lab of the Future...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read